Work

Preclinical Efficacy of TGF-Beta Receptor I Kinase Inhibitor, Galunisertib, in Myelofibrosis

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.603.603

Authors: Lanzhu Yue, Matthias Bartenstein, Wanke Zhao, Wan-Ting Ho, Ling Zhang, Franck Rapaport, Ross L. Levine, Zonghong Shao, Zhizhuang Joe Zhao, Amit Verma, Pearlie K Epling-Burnette

Institutions: Tianjin Medical University General Hospital, Moffitt Cancer Center, Tianjin Medical University, Albert Einstein College of Medicine, OU Health, University of Oklahoma Health Sciences Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2532682183

FWCI: 0.164

Cites:

Cited by: 9

Related to: 10